Background
==========

A highly relevant topic in biomedicine concerns the conditions of genotoxic stress that damages the genetic integrity of human cells. Genotoxic stress is induced by environmental agents such as ionizing radiation, ultraviolet (UV) light,[@b1-aabc-2-125] or chemical pollutants (eg, cigarette smoke).[@b2-aabc-2-125] Genotoxic stress triggers the activation of a complex network of signal transduction pathways collectively referred to as the DNA damage response.[@b3-aabc-2-125] The pathways are driven by 'sensor' proteins that sense the DNA damage, and transmit the signals via 'transducer' proteins to a multitude of 'effector' proteins, which induce a cellular response including mechanisms to slow down or block cell proliferation at so-called cell-cycle checkpoints,[@b4-aabc-2-125] followed by DNA repair, senescence,[@b5-aabc-2-125] or elimination of damaged, hazardous cells by engaging apoptosis to avoid transformation into tumor cells.[@b6-aabc-2-125]

DNA double-strand breaks (DSBs) are among the most lethal types of DNA damage, and can be induced by ionizing radiation or topoisomerase inhibitors, both of which are commonly used in cancer treatment with the aim to eliminate tumor cells by apoptosis. The Mre11/Rad50/Nbs1 (MRN) sensor protein complex is among the first to be recruited to such lesions, mediating the autophosphorylation of ataxia telangiectasia mutated (ATM).[@b7-aabc-2-125] ATM can phosphorylate checkpoint kinase 2 (Chk2), p53, and breast cancer type 1 susceptibility protein (BRCA1), which are involved in mediating cell cycle arrest and DNA repair or apoptosis.[@b4-aabc-2-125] Moreover, DSBs can also cause a posttranslationally processed form of PIDD to enter the nucleus.[@b8-aabc-2-125],[@b9-aabc-2-125] Nuclear p53-induced protein with a death domain (PIDD) binds via receptor-interacting protein 1 (RIP1) to nuclear factor-kappa B (NF-κB) essential modulator (NEMO),[@b10-aabc-2-125] which then becomes sumoylated by protein inhibitor of activated STAT y (PIASy).[@b10-aabc-2-125],[@b11-aabc-2-125] Thereafter, ATM phosphorylates NEMO, followed by its monoubquitinylation and export to the cytosol.[@b11-aabc-2-125]--[@b14-aabc-2-125] Inside the cytosol, NEMO activates IκB kinase β (IKKβ)[@b11-aabc-2-125],[@b12-aabc-2-125] to phosphorylate inhibitors of κBs (IκBs), followed by their ubiquitinylation-mediated degradation.[@b15-aabc-2-125] Since NF-κB dimers are retained in the cytosol by binding to IκBs, degradation of the latter leads to release of NF-κB, enabling its entry into the nucleus to drive the transcription of dedicated target genes.[@b16-aabc-2-125],[@b17-aabc-2-125] NF-κB-regulated target genes mostly exert antiapoptotic effects. Therefore, a major reason for resistance of tumor cells against radio- and chemotherapy can be attributed to the activation of NF-κB impeding the efficient elimination of cancer cells.[@b18-aabc-2-125] Increase of the nuclear level of NF-κB has been observed in several human solid tumor cell lines and some breast tumors.[@b18-aabc-2-125] This is one of the reasons why the molecular mechanisms of genotoxic stress response, in particular, the NF-κB-related pathways are of high interest.

Despite the high clinical relevance of the genotoxic stress response, the molecular interplay is poorly understood, particularly due to the high complexity of related signaling pathways, leading to the complication for finding promising drug targets for therapeutic treatments. Therefore, systems biological approaches might be of high value to give new insights into the understanding of the complex cellular networks. The prevailing formalism to model cellular networks is kinetic analysis, which has been mainly applied to signaling networks of smaller size. Qualitative (ie, parameter-free) models enable the computational representation and analysis of even large-scale signaling networks. A functional analysis of the network structure already enables researchers to address important issues, such as detection of network-wide functional interdependencies, identification of intervention strategies and predictions on the effects of perturbations. Boolean networks have been shown to be a useful tool for qualitative modeling of biological processes, particularly due to their computational simplicity.[@b19-aabc-2-125]--[@b22-aabc-2-125] Recently, a particular representation of logical networks, logical interaction hypergraphs has been shown to be well suitable for visualization and qualitative analyses of logical models of signal transduction networks.[@b23-aabc-2-125]--[@b25-aabc-2-125] Using this *in silico* approach, putative therapeutic targets in human signal transduction pathways induced by the pathogen *Helicobacter pylori* have been identified.[@b26-aabc-2-125]

Here, we present a logical model of the DNA-damage response in human epithelial cells with the major focus on the induction of the NF-κB system by DNA double-strand breaks. By simulating treatment of tumor cells with ionizing radiation and the topoisomerase II inhibitor VP16 (VePesid^®^, etoposide), we identified putative target molecules to impede tumor cell survival by abrogating activation of NF-κB while leaving apoptotic pathways unaffected. Further, our results give new insights into the understanding of complex signaling pathways, in particular the role of NF-κB in response to genotoxic stress.

Methods
=======

Data mining
-----------

For the Boolean network assembly we screened the relevant literature through PubMed and accessed further data on signaling pathways via curate protein--protein interaction databases.[@b27-aabc-2-125],[@b28-aabc-2-125] Large amounts of published experimental works were evaluated and only high quality data from experiments using human epithelial cells were used for modeling. Information on intracellular localization of proteins were retrieved from the LOCATE database[@b29-aabc-2-125] if this has not been indicated in the analyzed publications.

Logical model construction and analysis
---------------------------------------

For construction, visualization, and structural analyses of the signal transduction network, we employed the logical modeling framework of logical interaction hypergraphs.[@b23-aabc-2-125]--[@b26-aabc-2-125] Logical interaction hypergraphs are based on a special representation of Boolean functions, known as 'sum of products', which requires only AND, OR, and NOT operators for describing the logical relationships. In a logical network, nodes typically correspond to variables that can attain only discrete values; in the simplest (Boolean) case, each species can only be 'on' (ie, 'active' or 'present') or 'off' (ie, 'inactive' or 'absent'). Hence, each node is considered as a binary variable. A Boolean function is assigned to each node, determining under which conditions it is 'on' or 'off'. Interaction graphs are only capable of representing dependencies between two species. Therefore, in interaction graphs, every relationship is represented by an arc, connecting one tail (start) node with one head (end) node. A species may be activated by several distinct signaling events independently. This is represented by a logical OR connection of all arcs sharing the same head node. Therefore, each arc represents one means by which the species represented by the head node becomes active. However, in signaling networks, an interaction often represents a relationship between more than two species. For example, DSBs arise (are 'on') if both camptothecin and a topoisomerase I are present (ie, both are 'on'). This logical AND connection is represented by a hyperarc: the two tail nodes reflect the premise, that both of them have to be 'on' in order to activate the head note. Generally, a hyperarc can have an arbitrary number of start and end nodes, ie, can have arbitrary cardinality. Again, any hyperarcs pointing into the same node are connected by a logical OR. Moreover, inhibiting influences are represented by a logical 'NOT'.

The network diagram was constructed using the software CellDesigner 4.0.1 (The Systems Biology Institute, Tokyo, Japan).[@b30-aabc-2-125] We analyzed the logical model with the software CellNetAnalyzer 9.0 (*CNA*), a MATLAB package for graph-theoretical and logical analyses (The MathWorks, Natick, MA, USA).[@b24-aabc-2-125]

We studied the qualitative effects of input stimuli on downstream signaling events and on the logical pattern of outputs by computing logical steady states (LSS) of the network. [@b23-aabc-2-125] Importantly, the calculation of LSS also provides the basis for calculations of minimal intervention sets,[@b23-aabc-2-125],[@b24-aabc-2-125] which are defined as minimal sets of network elements that are to be removed (by knockout, knockdown or inhibition) or to be added (by activation) to achieve a certain intervention goal. *CNA* enables the setting of a maximum cardinality (maximum number of interventions allowed) for each minimal intervention set calculation.

Some functions of *CNA* operate on the level of the interaction graph underlying the logical model. The projection of a logical model to its underlying interaction graph can be conducted easily if a logical network is given in logical interaction hypergraph representation as in *CNA* (all the AND connections (hyperarcs) are being split into arcs). Within the interaction graph model one may then calculate graph-theoretical properties of the network including signaling paths, or the dependency matrix.[@b23-aabc-2-125],[@b24-aabc-2-125] The latter reveals functional interdependencies between each pair of species, eg, revealing whether a species *i* is an activator (ie, there are only positive paths) or an inhibitor (ie, there are only negative paths) or an ambivalent factor (ie, positive and negative paths to the selected species exist) for another species *j*. This feature facilitates qualitative predictions of the effects of perturbations or knockout experiments.

Results and discussion
======================

Boolean network of genotoxic stress-induced signal transduction
---------------------------------------------------------------

Based on quality-controlled published data gained from experiments using human epithelial cell lines, we built a Boolean network of NF-κB signal transduction in response to genotoxic stress ([Figure 1](#f1-aabc-2-125){ref-type="fig"}). The network was drawn according to the recently released Systems Biology Graphical Notation process diagram level 1,[@b31-aabc-2-125] which facilitates the communication of knowledge about signal transduction networks.

The model encompasses 69 species connected by 72 reactions and reflects the typical structure of signaling networks. Therein, genotoxic stimuli constitute the input layer (top of the network). The signals will be transmitted to the intermediate layer, and processed. Eventually, the processed signals are connected to proteins in the output layer (bottom), eg, resulting in apoptosis, as indicated by dashed lines. The numbers assigned to the interactions in [Figure 1](#f1-aabc-2-125){ref-type="fig"} correspond to the numbers of the model reactions (equations) listed in [Table 1](#t1-aabc-2-125){ref-type="table"}. All model species are listed in [Table 2](#t2-aabc-2-125){ref-type="table"}. The proteins linked to apoptosis or cell survival are indicated in [Table 3](#t3-aabc-2-125){ref-type="table"}.

Network-wide interdependencies revealed by the logical model
------------------------------------------------------------

For the analysis of the model, we calculated network-wide interdependencies comprehensively displayed in the dependency matrix ([Figure 2](#f2-aabc-2-125){ref-type="fig"}). This matrix indicates the type of the impact of a certain species (left) on another species (bottom), regardless of the type of stimulus. For instance, it can be inferred from [Figure 2](#f2-aabc-2-125){ref-type="fig"}, that ataxia telangiectasia and Rad3-related (ATR), which forms a complex with ATR interacting protein (ATRIP), has an inhibitory effect on Bcl-3/p52/p52. ATR activates p53 by phosphorylating it at serine 15 (equation 49, [Table 1](#t1-aabc-2-125){ref-type="table"}).[@b32-aabc-2-125] Additionally, ATR phosphorylates checkpoint kinase 2 (Chk2) (equation 60),[@b33-aabc-2-125],[@b34-aabc-2-125] which subsequently initiates the degradation of murine double minute X (MDMX) (equation 66).[@b35-aabc-2-125] Notably, MDMX itself ubiquitinylates p53, leading to degradation of p53.[@b35-aabc-2-125] Thus, ATR-mediated degradation of MDMX stabilizes p53, which in turn initiates degradation of Bcl-3 (equation 40).[@b36-aabc-2-125] This represents an inhibition in a logical sense, whereby the formation of the Bcl-3/p52/p52 complex (equation 41) is impeded, which leads to the inactivation of the NF-κB complex p52/p52[@b36-aabc-2-125] and further induces apoptosis. Moreover, the MDMX molecule itself can be ubiquitinylated by the E3 ligase murine double minute 2 (MDM2), leading to degradation of MDMX (equation 67), thus MDM2 stabilizes p53 by exerting an inhibitory effect on MDMX.[@b35-aabc-2-125],[@b37-aabc-2-125] Interestingly, MDM2 is able to ubiquitinylate p53 as well, which could also result in p53 degradation (equations 39, 49, 53, 58, and 65).[@b38-aabc-2-125] Therefore, in terms of logical interaction hypergraphs, MDM2 is an ambivalent factor for p53 and Bcl-3/p52/p52.

Apart from ATR, breast cancer type 1 susceptibility protein (BRCA1) exerts also an inhibitory effect on the formation of the Bcl-3/p52/p52 complex through the ataxia telangiectasia mutated (ATM)-mediated phosphorylation of p53 (serine 15) in a BRCA1-dependent manner (equation 53).[@b39-aabc-2-125]--[@b41-aabc-2-125] Thus, BRCA1 acts as an inhibitor of the Bcl-3/p52/p52 complex in a logical sense.

Furthermore, our model predicted candidate kinases for MDMX, which are crucial for the degradation of MDMX. Previous studies have shown that the genotoxic stress-induced degradation of MDMX can be mediated not only by the wortmannin-sensitive kinase ATM but alternatively also by other wortmannin-sensitive kinases.[@b42-aabc-2-125],[@b35-aabc-2-125] Our network analysis revealed ATM, Chk2 (equation 66) and ATR (equation 60) as genotoxic stress-induced kinases, which could phosphorylate MDMX.[@b33-aabc-2-125]--[@b35-aabc-2-125],[@b37-aabc-2-125],[@b43-aabc-2-125] Since Chk2 itself is not wortmannin-sensitive, we predicted ATR as an additional kinase crucial for MDMX phosphorylation-mediated degradation, whereby Chk2 is activated by ATR (equation 60).[@b33-aabc-2-125],[@b34-aabc-2-125]

Logical model of signal transduction induced by genotoxic stress
----------------------------------------------------------------

In clinical practice, many cancers are treated with combined radio- and chemotherapy, which have a synergistic effect.[@b44-aabc-2-125] Goal of this therapy is to induce apoptosis in treated tumor cells to eliminate the tumor. Using the logical model, we simulated the induction of the signal transduction in response to combined radio- and chemotherapy caused by ionizing radiation (equation 1) and VP16 (equation 4). This scenario mimics for instance treatment of lung cancer in patients.[@b44-aabc-2-125]

Ionizing radiation and VP16 induce activation of ATM (equations 7 to 9) and ATR (equations 54, 56) ([Figure 3](#f3-aabc-2-125){ref-type="fig"}), which subsequently (ATM equation 53 and ATR equation 49) phosphorylate p53 at serine 15 leading to the activation of the expression of numerous proapoptotic genes.[@b45-aabc-2-125] Moreover, p53 phosphorylated at serine 15 leads to the degradation of Bcl-3, a binding partner and transcriptional coactivator of the NF-κB subunit p52. Upon degradation of Bcl-3, HDAC1 binds to the NF-κB subunit p52 leading to repression of the antiapoptotic p52 target genes (equations 40, 41, 72).[@b36-aabc-2-125]

Simultaneously, DNA damage by DSBs can induce PIDD to form a complex with RIP-associated ICH-1/CED-3 homologous protein with a death domain (RAIDD) and caspase-2 (equation 51), constituting another pathway resulting in caspase-2 activation and apoptosis in epithelial cells and Jurkat T cells.[@b8-aabc-2-125],[@b10-aabc-2-125],[@b46-aabc-2-125] However, two other reports suggest PIDD-independent caspase-2 activation and apoptosis following DNA damage in lymphocytes of mice and mouse embryo fibroblasts.[@b47-aabc-2-125],[@b48-aabc-2-125] Thus, the differences may be inherent to the cell types analyzed, as suggested by Manzl and colleagues.[@b47-aabc-2-125] Further, DNA damage-induced regulation of the different PIDD isoforms is complex. DSBs induce upregulation of the PIDD isoform 3, and in addition proteolytic processing of PIDD varies among the isoforms of PIDD.[@b8-aabc-2-125] Nevertheless, PIDD exerts a prominent role in DNA damage-induced apoptosis. An important role of PIDD in NF-κB activation is undoubtedly.

It is well known that the activation of NF-κB in response to radio- and chemotherapy plays a key role in the therapeutic resistance by activation of antiapoptotic genes. For this reason, it is eligible to inhibit the NF-κB activation and enforce the expression of the proapoptotic genes ensuring the elimination of tumor cells.[@b18-aabc-2-125] Therefore, in our *in silico* predictions, we focused on the identification of putative target structures suitable for abrogation of expression of NF-κB-regulated antiapoptotic genes.

By calculating minimal intervention sets with *CNA*, we identified PIDD as a target structure ([Figure 4](#f4-aabc-2-125){ref-type="fig"}). Inhibition of the binding of PIDD to RIP1 will block activation of genotoxic stress-induced NF-κB, and the desired induction of apoptosis will be achieved. PIDD exists in several isoforms. Isoforms 1 and 3 are involved in activation of caspase-2 leading to apoptosis (equation 51), isoform 2 is exclusively involved in activation of NF-κB.[@b8-aabc-2-125] Further, RIP1 or PIASy represent additional candidates, which are crucial for genotoxic stress-induced NF-κB activation. Herein, biochemical studies already identified PIDD[@b9-aabc-2-125] and RIP1[@b10-aabc-2-125] as mediators in activation of NF-κB by DNA DSBs. Additionally, we identified the MRN complex and ATM as putative target structures to prevent activation of NF-κB. However, inhibition of MRN or ATM would also abrogate some of the pathways leading to activation of the proapoptotic proteins p53(P)S15 and E2F-1(P)S364. Therefore, the MRN complex and ATM might be less suitable therapeutic targets.

Conclusions
===========

We presented a Boolean network model of signal transduction induced by genotoxic stress in human epithelial cells with a special emphasis on NF-κB activation and apoptosis, which reveals the important functional interdependencies of protein activities. Recently, two Boolean network studies of apoptosis have been published. According to a study focusing on apoptosis induced by TNF and cell survival pathways induced by growth factors,[@b49-aabc-2-125] the irreversibility of apoptosis mostly relies on positive feedback loops, while the stability of the cell survival states depends more on the presence of external prosurvival signals. Another study focused on apoptotic pathways induced by Fas ligand in hepatocytes. The authors integrated different apoptosis pathways and investigated several crosstalk possibilities. Four stable states of the network were identified, two states comprising cell survival and two states leading to apoptosis.[@b50-aabc-2-125] Both reports focused on global network properties rather than on putative therapeutic applications. To our knowledge, until now, no model focusing on NF-κB in genotoxic stress response has been published in such extent, in particular, with the focus on identification of target structures, which may potentiate radio- and chemotherapy. Furthermore, we identified the putative molecular targets PIDD, RIP1 and PIASy to abrogate the activation of NF-κB while leaving the apoptotic pathways unaffected, therefore resulting in apoptosis of tumor cells.

Overall, the model presented in our study identified target structures, which may increase the efficacy of radio-and chemotherapy of tumors. Furthermore, our study provides for the first time a holistic model for both studying and understanding the signaling pathways in response to genotoxic stress, which may facilitate the understanding and interpretation of the large amount of published experimental data, hence indicating new targets for therapeutic strategies or drug discovery.
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![Logical model of genotoxic stress-induced signal transduction with a special emphasis on NF-κB activation. Hyperarcs are numbered according to the Boolean equations in [Table 1](#t1-aabc-2-125){ref-type="table"}. Genotoxic stimuli induce DNA damage, leading to activation of output layer proteins (bottom part); some of these have been linked (dashed lines, not included in the Boolean model) to apoptosis.\
**Abbreviation:** NF-κB, nuclear factor-κB.](aabc-2-125f1){#f1-aabc-2-125}

![Dependency matrix. The dependency matrix displays network-wide interdependencies. The color of matrix element M~ij~ defines the type of the impact of species *i* (left hand side) on *j* (bottom).[@b23-aabc-2-125]\
**Notes:** Green, activator; red, inhibitor; yellow, ambivalent factor; black, no effect.](aabc-2-125f2){#f2-aabc-2-125}

![Logical model of genotoxic stress-induced signal transduction. Each species and each hyperarc has an associated text box displaying its activity state. Blue boxes indicate values fixed prior computing the logical steady state (ie, the network response), green boxes ('on') indicate active species, red boxes ('off') indicate inactive or absent species.](aabc-2-125f3){#f3-aabc-2-125}

![*In silico* inhibition of PIDD promotes apoptosis. Inhibition of the binding of PIDD to RIP1 abolishes activation of NF-κB in cells treated with VP16 and ionizing radiation. The formation of the proapoptotic complex composed of PIDD/RAIDD/caspase2 remains unaffected. The inhibition is proposed to increase the efficacy of tumor treatment (chemosensitization) with DSB-inducing agents. For the text box colors see [Figure 1](#f1-aabc-2-125){ref-type="fig"}.\
**Abbreviations:** DSB, double-stranded breaks; NF-κB, nuclear factor-κB; PIDD, p53-induced protein with a death domain; RAIDD, RIP-associated ICH-1/CED-3 homologous protein with a death domain; RIP1, receptor-interacting protein 1.](aabc-2-125f4){#f4-aabc-2-125}

###### 

The Boolean model reactions. Interactions of the logical model

  Boolean equations                                                   Explanations and references
  ------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1\. I R → DNA DSBs                                                  Ionizing radiation causes DNA double-strand breaks in all cell types[@b51-aabc-2-125]
  2\. SN 38 · topoisomeraseI → DNA DSBs                               SN 38 causes DNA double-strand breaks by inhibiting topoisomerase I[@b52-aabc-2-125]
  3\. camptothecin · topoisomeraseI → DNA DSBs                        Camptothecin causes DNA double-strand breaks by inhibiting topoisomerase I[@b52-aabc-2-125]
  4\. VP16 · topoisomeraseII → DNA DSBs                               VP16 causes DNA double-strand breaks by inhibiting topoisomerase II[@b53-aabc-2-125]
  5\. daunomycin · topoisomeraseII → DNA DSBs                         Daunomycin causes DNA double-strand breaks by inhibiting topoisomerase II[@b54-aabc-2-125]
  6\. doxorubicin · topoisomeraseII → DNA DSBs                        Doxorubicin causes DNA double-strand breaks by inhibiting topoisomerase II[@b55-aabc-2-125]
  7\. DNA DSBs · MRN → ATM(P)                                         The MRN complex facilitates autophosphorylation of ATM at serine 1981[@b39-aabc-2-125],[@b56-aabc-2-125],[@b57-aabc-2-125]
  8\. ATM(P) · MRN → MRN(P)                                           Activated ATM phosphorylates serine 343 of Nbs1 within the MRN complex[@b58-aabc-2-125]
  9\. DNA DSBs · MRN(P)→ ATM(P)                                       The phosphorylated MRN complex facilitates autophosphorylation of ATM at serine 1981[@b39-aabc-2-125],[@b56-aabc-2-125],[@b57-aabc-2-125]
  10\. DNA DSBs → PIDD                                                DNA double-strand breaks activate PIDD (by autocatalytic cleavage, potentially expression)[@b8-aabc-2-125],[@b9-aabc-2-125]
  11\. PIDD → PIDD/RIP1/NEMO                                          Activated PIDD enters the nucleus and forms a complex with RIP1 and NEMO[@b10-aabc-2-125],[@b9-aabc-2-125]
  12\. PIASy · PIDD/RIP1/NEMO → PIDD/RIP1/NEMO(S)                     PIASy sumoylates NEMO within the PIDD/RIP1/NEMO complex[@b10-aabc-2-125],[@b11-aabc-2-125]
  13\. ATM(P) · PIDD/RIP1/NEMO(S) → ATM(P)/NEMO(P)                    Upon sumoylation, ATM phosphorylates NEMO at serine 85[@b12-aabc-2-125],[@b13-aabc-2-125]
  14\. ATM(P)/NEMO(P) → nuclear ATM(P)/NEMO(Ub)                       Upon phosphorylation, NEMO becomes monoubiquitinylated[@b12-aabc-2-125],[@b13-aabc-2-125]
  15\. Nuclear ATM(P)/NEMO(Ub) · Ca^2+^ → cytosolic ATM(P)/NEMO(Ub)   Export of ATM(P)/NEMO(Ub) to the cytoplasm is dependent on Ca^2+^[@b12-aabc-2-125],[@b14-aabc-2-125]
  16\. Cytosolic ATM(P)/NEMO(Ub) → ATM(P)/NEMO(Ub)/IKKβ               ATM(P)/NEMO(Ub) binds to IKKβ (or the whole IKK complex?)[@b11-aabc-2-125],[@b12-aabc-2-125]
  17\. ATM(P)/NEMO(Ub)/IKKβ → IKK complex(P)                          IKK becomes activated by DNA double-strand breaks[@b14-aabc-2-125],[@b59-aabc-2-125]
  18\. Camptothecin → NIK(P)                                          Camptothecin activates NF-κB partly via NIK[@b60-aabc-2-125]
  19\. NI K(P) → IKK complex(P)                                       NIK activates IKK[@b60-aabc-2-125]
  20\. Doxorubicin → MEK(P)                                           Doxorubicin activates MEK[@b61-aabc-2-125]
  21\. MEK(P) → ERK(P)                                                MEK activates ERK1/2[@b61-aabc-2-125]
  22\. ERK(P) → p90(P)                                                ERK1/2 mediates binding of p90^rsk^ to IKKβ, leading to phosphorylation of both[@b61-aabc-2-125]
  23\. p90(P) → IKK complex(P)                                        ERK1/2 mediates binding of p90^rsk^ to IKKβ, leading to phosphorylation of both[@b61-aabc-2-125]
  24\. Cisplatin → Oxo8-Guanine                                       Cisplatin leads to formation of Oxo8-Guanine lesions[@b62-aabc-2-125]
  25\. UVA → Oxo8-Guanine                                             UVA leads to formation of Oxo8-Guanine lesions[@b62-aabc-2-125]
  26\. I L-1 · Oxo8-Guanine → IKK complex(P)                          IL-1 and Oxo8-Guanine synergistically activate IKK to phosphorylate IκBα[@b62-aabc-2-125]
  27\. UVB → pyrimidine dimers                                        UVB leads to formation of pyrimidine dimer lesions[@b62-aabc-2-125]
  28\. I L-1 · pyrimidine dimers → IKK complex(P)                     IL-1 and pyrimidine dimers synergistically activate IKK to phosphorylate IκBα[@b62-aabc-2-125]
  29\. UVB → nuclear NF-κB                                            UVB induces binding of NF-κB to DNA[@b63-aabc-2-125],[@b64-aabc-2-125]
  30\. UVC → PI3K(P)                                                  UVC triggers activation of PI3K[@b65-aabc-2-125]
  31\. PI3K(P) → AKT2(P)                                              Activated PI3K mediates phosphorylation of AKT2[@b65-aabc-2-125]
  32\. AKT2(P) → IKKα(P)                                              Phosphorylated AKT2 phosphorylates IKKα at threonine 23[@b65-aabc-2-125]
  33\. !IKKα(P) · !IKK complex(P) · !CK2 → IκBα                       Several forms of genotoxic stress trigger IKK or CK2 to phosphorylate IκBα, leading to its proteolysis[@b59-aabc-2-125],[@b60-aabc-2-125],[@b62-aabc-2-125],[@b65-aabc-2-125]--[@b71-aabc-2-125]
  34\. !IκBα → cytosolic NF-κB                                        Degradation of IκBα releases NF-κB[@b15-aabc-2-125]
  35\. Cytosolic NF-κB → nuclear NF-κB                                Released NF-κB enters the nucleus[@b15-aabc-2-125]
  36\. UVC → p38^MAPK^(P)                                             UVC activates p38^MAPK\ 70^
  37\. p38^MAPK^(P) → CK2                                             Activated p38^MAPK^ activates CK2[@b70-aabc-2-125]
  38\. !IKK complex(P) → IκBβ                                         Genotoxic stress-triggered phosphorylation of IKK mediates proteolysis of IκBβ[@b60-aabc-2-125]
  39\. UVC · !MDMX · !MDM2 → p53(P)S15                                UVC triggers phosphorylation of p53 at serine 15, MDM2 and MDMX ubiquitinylate p53, leading to its proteolysis[@b35-aabc-2-125],[@b36-aabc-2-125],[@b38-aabc-2-125],[@b72-aabc-2-125]
  40\. !p53(P)S15 → Bcl-3                                             p53(P)S15 destabilizes Bcl-3[@b36-aabc-2-125]
  41\. Bcl-3 · !HDAC1 → Bcl-3/p52/p52                                 Bcl-3 competes with HDAC1 for binding to the NF-κB p52/p52[@b36-aabc-2-125]
  42\. Bcl-3/p52/p52 → Cyclin D1                                      Bcl-3/p52/p52 binds to DNA and drives the expression of Cyclin D1[@b36-aabc-2-125]
  43\. UVB · nuclear NF-κB → Egr-1                                    UVB activates NF-κB to drive the expression of Egr-1 in several cell lines[@b63-aabc-2-125],[@b73-aabc-2-125],[@b74-aabc-2-125]
  44\. Egr-1 → Gadd45α                                                Egr-1 drives the expression of Gadd45α in several cell lines[@b63-aabc-2-125]
  45\. Gadd45α → caspase3                                             Gadd45α activates caspase-3[@b63-aabc-2-125]
  46\. Egr-1 → Gadd45β                                                Egr-1 drives the expression of Gadd45β in several cell lines[@b63-aabc-2-125]
  47\. Gadd45β → caspase3                                             Gadd45β activates caspase-3[@b63-aabc-2-125]
  48\. caspase3 → caspase7                                            caspase-3 becomes activated along with caspase-7[@b63-aabc-2-125]
  49\. ATR/ATRIP · !MDMX · !MDM2 → p53(P)S15                          ATR (which is bound to ATRIP) phosphorylates p53 at serine 15[@b32-aabc-2-125],[@b75-aabc-2-125], MDM2 and MDMX destabilize p53 (reaction 39).
  50\. p53(P)S15 → p21                                                p53(P)S15 drives the expression of p21[@b76-aabc-2-125]--[@b78-aabc-2-125]
  51\. PIDD → PIDD/RAIDD/caspase2                                     Activated PIDD binds via RAIDD to caspase-2, which becomes activated.[@b8-aabc-2-125],[@b10-aabc-2-125],[@b46-aabc-2-125]
  52\. ATM(P) → BARD1/BRCA1(P)                                        Activated ATM phosphorylates serines 1387, 1423 and 1524 of BRCA1, which requires binding to BARD1 for stability[@b40-aabc-2-125],[@b79-aabc-2-125],[@b80-aabc-2-125]
  53\. ATM(P) · !MDMX · !MDM2 · BARD1/BRCA1(P) → p53(P)S15            Activated ATM phosphoryltes p53 at serine 15, dependent on phosphorylated BRCA1.[@b39-aabc-2-125],[@b40-aabc-2-125],[@b41-aabc-2-125] MDM2 and MDMX destabilize p53 (reaction 39).
  54\. ATM(P) → ATR/ATRIP                                             Activated ATM recruits ATR/ATRIP to nuclear foci, potentially via the MRN complex[@b75-aabc-2-125],[@b81-aabc-2-125]
  55\. DNA DSBs → RPA(P)                                              DNA double-strand breaks are associated with single strand breaks, to where RPA is recruited to within nuclear foci; it is unclear whether RPA is indeed required for MRN complex assembly[@b57-aabc-2-125],[@b81-aabc-2-125]
  56\. RPA(P) → ATR/ATRIP                                             Activated RPA recruits ATR/ATRIP to DNA[@b75-aabc-2-125]
  57\. ATR/ATRIP → Chk1(P)                                            Activated ATR phosphorylates Chk1 at serines 317 and 345[@b81-aabc-2-125],[@b82-aabc-2-125]
  58\. Chk1(P) · !MDMX · !MDM2 → p53(P)S20                            Activated Chk1 phosphorylates p53 at serine 20.[@b79-aabc-2-125],[@b83-aabc-2-125] MDM2 and MDMX destabilize p53 (reaction 39).
  59\. ATM(P)→ Chk2(P)                                                Activated ATM phosphorylates Chk2 at threonine 68[@b84-aabc-2-125]
  60\. ATR/ATRIP → Chk2(P)                                            Activated ATR phosphorylates Chk2 at threonine 68.[@b33-aabc-2-125],[@b34-aabc-2-125]
  61\. !Chk1(P) · !Chk2(P) → Cdc25A                                   Chk1 and Chk2 phosphorylate Cdc25A at serines 76 and 123, respectively, leading to its ubiquitinylation-mediated degradation[@b85-aabc-2-125],[@b86-aabc-2-125]
  62\. Cdc25A → Cdk2                                                  Cdc25A activates Cdk2 by dephosphorylating it at tyrosine residues[@b87-aabc-2-125]
  63\. Chk2(P) → Cdc25C(P)                                            Activated Chk2 phosphorylates Cdc25C at serine 216[@b88-aabc-2-125]
  64\. Chk2(P) → E2F-1(P)                                             Activated Chk2 stabilizes E2F-1 by phosphorylation at serine 364[@b89-aabc-2-125]
  65\. Chk2(P) · !MDMX · !MDM2 → p53(P)S20                            Activated Chk2 mediates phosphorylation of p53 at serine 20,[@b90-aabc-2-125] MDM2 and MDMX destabilize p53 (reaction 39).
  66\. !ATM(P) · !Chk2(P) → MDMX                                      MDMX becomes phosphorylated by Chk2 at serines 342 and 367 and by activated ATM at serine 403, leading to ubiquitinylation-mediated degradation of MDMX[@b35-aabc-2-125],[@b37-aabc-2-125],[@b43-aabc-2-125]
  67\. !MDM2 · !c-Abl(P) → MDMX                                       The E3 ligase MDM2 polyubiquitinylates MDMX, leading to its degradation,[@b35-aabc-2-125],[@b37-aabc-2-125],[@b43-aabc-2-125] this works only as long as c-Abl itself is not destabilized (see reactions 68, 69).
  68\. ATM(P) → c-Abl(P)                                              Activated ATM phosphorylates c-Abl.[@b91-aabc-2-125],[@b92-aabc-2-125]
  69\. !c-Abl(P) → MDM2                                               Activated c-Abl mediates phosphorylation of MDM2 at serine 397, leading to its ubiquitinylation-mediated proteolysis[@b38-aabc-2-125]
  70\. DNA DSBs → DNA-PK                                              DNA double-strand breaks lead to DNA-PK-dependent phosphorylation of Sp1[@b93-aabc-2-125]
  71\. DNA-PK → Sp1(P)                                                DNA double-strand breaks lead to DNA-PK-dependent phosphorylation of Sp1[@b93-aabc-2-125]
  72\. !Bcl-3 → HDAC1                                                 In the absence of Bcl-3, HDAC1 binds to p52 dimers[@b36-aabc-2-125]

**Notes:** An exclamation mark denotes a logical NOT and a product sign (·) indicates an AND operation.

###### 

The Boolean model species

  Species IDs                 Full names
  --------------------------- ----------------------------------------------
  AKT2(P)                     
  ATM(P)                      ATM(P)S1981
  ATM(P)/NEMO(P)              ATM(P)S1981/NEMO(P)S85
  ATM(P)/NEMO(Ub)/IKKβ        ATM(P)S1981/NEMO(Ub)/IKKβ
  ATR/ATRIP                   
  BARD1/BRCA1(P)              BARD1/BRCA1(P)1387(P)S1423(P)1524
  Bcl-3                       
  Bcl-3/p52/p52               
  Ca^2+^                      
  c-Abl(P)                    c-Abl(P) (unspec. phosphoryl. site)
  Camptothecin                
  Caspase3                    
  Caspase7                    
  Cdc25C(P)                   Cdc25C(P)S216
  Cdc25A                      
  Cdk2                        
  Chk1(P)                     Chk1(P)S317(P)S345
  Chk2(P)                     Chk2(P)T68
  Cisplatin                   
  CK2                         
  Cyclin D1                   
  Cytosolic ATM(P)/NEMO(Ub)   Cytosolic ATM(P)S1981/NEMO(Ub)
  Cytosolic NF-κB             
  Daunomycin                  
  DNA_DSBs                    
  DNA-PK                      
  Doxorubicin                 
  E2F-1(P)                    E2F-1(P)S364
  Egr-1                       
  ERK(P)                      ERK(P) (unspec. phosphoryl. site)
  Gadd45α                     
  Gadd45β                     
  HDAC1                       
  IKK complex(P)              IKKα/IKKβ/NEMO(P) (unspec. phosphoryl. site)
  IKKα(P)                     IKKα(P)T23
  IL-1                        
  IR                          
  IκBα                        
  IκBβ                        
  MDM2                        
  MDMX                        
  MEK(P)                      MEK(P) (unspec. phosphoryl. site)
  MRN                         Mre11/Rad50/Nbs1
  MRN(P)                      Mre11/Rad50/Nbs1(P)S343
  NIK(P)                      
  Nuclear ATM(P)/NEMO(Ub)     Nuclear ATM(P)S1981/NEMO(Ub)
  Nuclear NF-κB               
  Oxo8-Guanine                
  p21                         
  p38^MAPK^(P)                (unspec. phosphoryl. site)
  p53(P)S15                   
  p53(P)S20                   
  p90(P)                      (unspec. phosphoryl. site)
  PI3K(P)                     
  PIASy                       
  PIDD                        
  PIDD/RAIDD/caspase2         
  PIDD/RIP1/NEMO              
  PIDD/RIP1/NEMO(S)           PIDD/RIP1/NEMO(SUMO-1) K277(SUMO-1)K309
  Pyrimidine_dimers           
  RPA(P)                      RPA(P) (unspec. phosphoryl. site)
  SN38                        
  Sp1(P)                      Sp1(P) (unspec. phosphoryl. site)
  Topoisomerasei              
  Topoisomeraseii             
  UVA                         
  UVB                         
  UVC                         
  VP16                        

**Abbreviations:** P, phosphorylation; S, sumoylation (SUMO-1); Ub, ubiquitinylation.

###### 

Proteins of the output layer linked to apoptosis or cell survival

  Network components linked to apoptosis and cell survival pathways   Explanations and references
  ------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------
  NF-κB (includes 52 dimers)                                          In most cases, NF-κB triggers antiapoptotic signaling[@b16-aabc-2-125]
  Caspases-3/7                                                        Caspases-3/7 promote apoptosis[@b63-aabc-2-125]
  p53(P)S15                                                           p53(P)S15 has proapoptotic functions[@b45-aabc-2-125]
  Caspase-2                                                           Caspase 2 promotes apoptosis upon activation in the PIDD/RAIDD/caspase2 complex[@b9-aabc-2-125],[@b46-aabc-2-125]
  E2F-1(P)S364                                                        E2F-1(P)S364 promotes p53-dependent and p53-independent apotosis[@b89-aabc-2-125],[@b94-aabc-2-125]

**Notes:** Activation of the proteins listed lead to either apoptotic or cell survival pathways.

[^1]: Present address: Department of Chemical Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany
